Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan · Delayed Price · Currency is TWD 31.50
-0.25 (-0.79%)
Sep 8, 2026, 1:30 PM CST
Nang Kuang Pharmaceutical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 363.56 | 345.67 | 301.54 | 378.48 | 401.2 | 417.12 |
Trading Asset Securities | - | - | - | - | 1.31 | 1.28 |
Cash & Short-Term Investments | 363.56 | 345.67 | 301.54 | 378.48 | 402.51 | 418.41 |
Cash Growth | 17.47% | 14.63% | -20.33% | -5.97% | -3.80% | 56.21% |
Accounts Receivable | 398.49 | 363.56 | 423.08 | 374.67 | 386.71 | 350.44 |
Other Receivables | 0.13 | 0.98 | 0.12 | 1.3 | 0.15 | 0.4 |
Receivables | 398.62 | 364.54 | 423.2 | 375.97 | 386.86 | 350.84 |
Inventory | 781.54 | 731.56 | 709.06 | 762.62 | 827.58 | 701.44 |
Prepaid Expenses | 18.04 | 24.23 | 20.36 | 20.61 | 23.38 | 20.71 |
Other Current Assets | 42.82 | 26.61 | 1.83 | - | - | - |
Total Current Assets | 1,605 | 1,493 | 1,456 | 1,538 | 1,640 | 1,491 |
Property, Plant & Equipment | 2,130 | 2,089 | 2,105 | 1,867 | 1,602 | 1,682 |
Long-Term Investments | 96.9 | 114.81 | 129.12 | 152.18 | 118.97 | 50.29 |
Other Intangible Assets | 8.76 | 5.28 | 4.34 | 5.2 | 3.87 | 5.21 |
Long-Term Deferred Tax Assets | 25.28 | 25.39 | 22.02 | 39.36 | 27.07 | 29.84 |
Other Long-Term Assets | 75.64 | 96.68 | 95.99 | 255.08 | 192.61 | 169.83 |
Total Assets | 3,941 | 3,823 | 3,813 | 3,856 | 3,585 | 3,429 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 210.73 | 211.55 | 210.38 | 166.8 | 254.3 | 224.34 |
Accrued Expenses | 110.93 | 122.32 | 113.99 | 100.61 | - | - |
Short-Term Debt | 340 | 460 | 450 | 580 | 370 | 479.99 |
Current Portion of Long-Term Debt | 39 | 8.93 | 19.86 | 12.5 | 12.5 | 12.5 |
Current Portion of Leases | 0.47 | 0.37 | 0.75 | 0.49 | 1.05 | 1.26 |
Current Income Taxes Payable | 26.83 | 22.64 | 11.78 | 2.7 | 57.01 | 46.61 |
Current Unearned Revenue | 100.97 | 121.42 | 123.9 | 127.97 | 142.49 | 131.55 |
Other Current Liabilities | 312.33 | 117.55 | 212.17 | 291.63 | 203.04 | 176.7 |
Total Current Liabilities | 1,141 | 1,065 | 1,143 | 1,283 | 1,040 | 1,073 |
Long-Term Debt | 301.87 | 186.39 | 167.26 | 112.5 | 25 | 37.5 |
Long-Term Leases | 3.01 | - | 0.37 | 0.07 | 0.59 | 1.55 |
Pension & Post-Retirement Benefits | 52.47 | 51.75 | 50.01 | 53.71 | 53 | 53.36 |
Long-Term Deferred Tax Liabilities | 0.31 | 0.68 | 0.35 | - | 1.2 | 0.26 |
Other Long-Term Liabilities | 30.3 | 30.1 | 30.1 | 30.1 | 53.33 | 23.06 |
Total Liabilities | 1,529 | 1,334 | 1,391 | 1,479 | 1,174 | 1,189 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,010 | 1,010 | 1,010 | 1,010 | 1,010 | 1,010 |
Additional Paid-In Capital | 164.22 | 245.01 | 325.8 | 426.79 | 457.09 | 482.34 |
Retained Earnings | 1,233 | 1,229 | 1,086 | 940.46 | 944.03 | 748.02 |
Comprehensive Income & Other | -0.04 | -0.04 | -0.04 | -0.03 | 0.02 | -0.04 |
Total Common Equity | 2,407 | 2,484 | 2,422 | 2,377 | 2,411 | 2,240 |
Minority Interest | 4.36 | 5.53 | - | - | - | - |
Shareholders' Equity | 2,412 | 2,490 | 2,422 | 2,377 | 2,411 | 2,240 |
Total Liabilities & Equity | 3,941 | 3,823 | 3,813 | 3,856 | 3,585 | 3,429 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 684.35 | 655.69 | 638.23 | 705.56 | 409.13 | 532.81 |
Net Cash (Debt) | -320.8 | -310.02 | -336.69 | -327.08 | -6.62 | -114.4 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -3.17 | -3.06 | -3.33 | -3.23 | -0.07 | -1.13 |
Filing Date Shares Outstanding | 100.99 | 100.99 | 100.99 | 100.99 | 100.99 | 100.99 |
Total Common Shares Outstanding | 100.99 | 100.99 | 100.99 | 100.99 | 100.99 | 100.99 |
Working Capital | 463.32 | 427.82 | 313.17 | 254.99 | 599.94 | 418.44 |
Book Value Per Share | 23.84 | 24.60 | 23.98 | 23.54 | 23.87 | 22.18 |
Tangible Book Value | 2,399 | 2,479 | 2,418 | 2,372 | 2,407 | 2,235 |
Tangible Book Value Per Share | 23.75 | 24.55 | 23.94 | 23.49 | 23.84 | 22.13 |
Land | 757.96 | 757.96 | 767.41 | 573.57 | 247.28 | 247.28 |
Buildings | 1,227 | 1,223 | 1,232 | 1,134 | 1,120 | 1,111 |
Machinery | 2,785 | 2,698 | 2,586 | 2,506 | 2,431 | 2,359 |
Construction In Progress | 124.45 | 109 | 56.54 | 26.79 | 36.53 | 41.57 |